KMB • Consumer staples • Household Products

Kimberly-Clark

Last closing price

$99.15

Valuations

Peter Lynch Fair Value
$59.12- 40.38%
Price/Earnings to Growth
1.08Fair
Price/Earnings to Growth & Dividend Yield
1.68Overvalued

Peter Lynch Fair Value

$59.12

- 40.38% below current price

Methodology

Kimberly-Clark's personal care and tissue products generate stable earnings from essential consumer staples like Huggies and Kleenex, though private label competition and commodity costs create pressure. The company's brand strength in diapers and tissues provides some pricing power. This calculation works moderately well, though mature categories and limited growth opportunities constrain earnings expansion.

Methodology

Kimberly-Clark often shows elevated PEG ratios given very modest growth in mature personal care categories. The company's value lies more in cash generation and dividend reliability than growth prospects. For mature consumer staples facing category maturity, valuation based on free cash flow yield and brand durability matters more than earnings growth multiples.

Methodology

Kimberly-Clark's substantial dividend yield with dividend aristocrat status is central to the investment thesis for this mature consumer staples company. The company has delivered decades of consecutive dividend increases despite category challenges. PEGY is essential for properly valuing Kimberly-Clark, where reliable dividend growth provides most of the total return given low-growth realities in mature tissue and diaper markets.

© 2026 WallstreetHive